SEC Form 4 · accession 0001179110-15-014473
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robin L Washington
Officer — EVP, CFO
Period of report
Nov 2, 2015
Accepted (ET)
Nov 4, 2015 · 4:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Nov 2, 2015 | S | 1,900 | $109.1284 | D | 92,396 | I | Trust |
| Common StockF3 | Nov 2, 2015 | S | 4,350 | $109.6105 | D | 88,046 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F2Sale prices reported for the transactions reported here range from $108.44 to $109.44. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F3Sale prices reported for the transactions reported here range from $109.46 to $109.85. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.